Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals
and is the fourth most common cause for renal replacement therapy worldwide. There have …

The European Association of Urology (EAU) Urolithiasis Guidelines Panel has prepared
these guidelines to help urologists assess evidence-based management of stones/calculi in …

Abstract The Urological Association of Asia, consisting of 25 member associations and one
affiliated member since its foundation in 1990, has planned to develop Asian guidelines for …

Objective To explore the efficacy of antibiotic prophylaxis and the different strategies used to
prevent infection in ureteroscopic lithotripsy (URL) by conducting a systematic review and …

ADPKD patients benefit from specialized care over their lifetimes, starting with diagnosis of
the condition with ongoing discussion of both the renal course and extra-renal issues. Both …

The purpose of this article is to review the hereditary renal cystic diseases that can manifest
in children and adults, with specific attention to pathogenesis and imaging features. Various …

7.1. 2.2 Location of the stone mass 19 7.1. 2.3 Total stone burden 20 7.1. 2.4 composition
and hardness of the stone 20 7.1. 2.5 Patient's habitus 21 7.1. 2.6 Performance of ESWL …

Background Patients with autosomal dominant polycystic kidney disease (ADPKD) often
need to undergo native nephrectomy and are candidates for kidney transplantation. The …

The management of urinary calculi in abnormal situations continues to pose challenges to
urologists. Abnormal situations include pregnancy, aberrant anatomy, kidney transplants …

Thousands of pathogenic variants in more than 100 genes can cause kidney cysts with
substantial variability in phenotype and risk of subsequent kidney failure. Despite an …